Brasofensine

From WikiMD.com Medical Encyclopedia

Brasofensine[edit | edit source]

Chemical structure of Brasofensine

Brasofensine is a pharmacological compound that has been investigated for its potential use in the treatment of Parkinson's disease and other neurological disorders. It is classified as a dopamine reuptake inhibitor, which means it works by blocking the reabsorption of dopamine into neurons, thereby increasing the availability of dopamine in the synaptic cleft.

Mechanism of Action[edit | edit source]

Brasofensine primarily acts by inhibiting the dopamine transporter (DAT), which is responsible for the reuptake of dopamine from the synaptic cleft back into the presynaptic neuron. By blocking this transporter, brasofensine increases the concentration of dopamine in the synaptic cleft, enhancing dopaminergic neurotransmission. This mechanism is particularly beneficial in conditions like Parkinson's disease, where there is a deficiency of dopamine in the striatum.

Potential Therapeutic Uses[edit | edit source]

Parkinson's Disease[edit | edit source]

Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra. The resulting dopamine deficiency leads to the hallmark symptoms of Parkinson's, including tremor, rigidity, and bradykinesia. By increasing dopamine levels, brasofensine has the potential to alleviate these symptoms.

Other Neurological Disorders[edit | edit source]

In addition to Parkinson's disease, brasofensine has been studied for its effects on other neurological conditions that involve dopaminergic dysfunction, such as attention deficit hyperactivity disorder (ADHD) and certain forms of depression. However, its efficacy and safety in these conditions require further investigation.

Development and Research[edit | edit source]

Brasofensine was initially developed by NeuroSearch, a Danish pharmaceutical company, and underwent several clinical trials to assess its safety and efficacy. Despite promising preclinical results, the development of brasofensine was eventually discontinued due to various challenges encountered during clinical trials, including issues related to efficacy and side effects.

Chemical Properties[edit | edit source]

Brasofensine is a synthetic compound with a complex chemical structure, as depicted in the accompanying image. Its molecular formula is C16H23NO2, and it belongs to the class of compounds known as piperidines.

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD